We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
- Authors
Fedele, Pasquale; Gregory, Gareth; Gilbertson, Michael; Shortt, Jake; Kumar, Beena; Opat, Stephen; Grigoriadis, George; Fedele, Pasquale L; Gregory, Gareth P
- Abstract
The article discusses the case of a patient with plasmablastic lymphoma (PBL) successfully managed with a combination of bortezomib and the chemotherapeutic regimen infusional dose-adjusted EPOCH which includes rituximab, etoposide, prednisolone, oncovin, cyclophosphamide and hydroxydaunorubicin. Topics discussed include the patient's clinical presentation and medical history, treatment tolerance and the patient's metabolic and clinical remission.
- Subjects
LYMPHOMA treatment; BORTEZOMIB; CANCER chemotherapy; RITUXIMAB; ETOPOSIDE; PREDNISOLONE; CYCLOPHOSPHAMIDE
- Publication
Annals of Hematology, 2016, Vol 95, Issue 4, p667
- ISSN
0939-5555
- Publication type
journal article
- DOI
10.1007/s00277-016-2601-6